Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality.
Weeke PE, Kellemann JS, Jespersen CB, Theilade J, Kanters JK, Hansen MS, Christiansen M, Marstrand P, Gislason GH, Torp-Pedersen C, Bundgaard H, Jensen HK, Tfelt-Hansen J.
Weeke PE, et al. Among authors: theilade j.
Eur Heart J. 2019 Oct 1;40(37):3110-3117. doi: 10.1093/eurheartj/ehz228.
Eur Heart J. 2019.
PMID: 31079148